Table 5.
Fitness ratings.
| Fitness ratings | Very poor-poor | Below average | Average | Above average | Good | Excellent |
|---|---|---|---|---|---|---|
| Completed at pace (96 ± 0 steps/min (mean ± SEM, range 96), 9 in.) number (%) | ||||||
| Total number in group n = 87a | 4 (5) | 5 (6) | 13 (15) | 18 (21) | 30 (34) | 17 (19) |
| Active chemotherapyb | ||||||
| Yes | 1 (4) | 3 (13) | 9 (39) | 3 (13) | 4 (17) | 3 (13) |
| No | 3 (5) | 2 (3) | 4 (6) | 15 (23) | 26 (41) | 14 (22) |
| Active anti-hormonal therapyc | ||||||
| Yes | 2 (4) | 2 (4) | 2 (4) | 12 (27) | 15 (33) | 12 (27) |
| No | 2 (5) | 3 (7) | 11 (26) | 6 (14) | 15 (36) | 5 (12) |
| Radiation therapy | ||||||
| Completed | 2 (8) | 0 (0) | 5 (19) | 6 (23) | 8 (31) | 5 (19) |
| None | 2 (3) | 5 (9) | 8 (14) | 10 (17) | 21 (36) | 12 (21) |
| Active | 0 (0) | 0 (0) | 0 (0) | 2 (67) | 1 (33) | 0 (0) |
| Presence of distant metastases | ||||||
| Yes | 0 (0) | 2 (29) | 1 (14) | 2 (29) | 1 (14) | 1 (14) |
| No | 4 (5) | 3 (4) | 12 (15) | 16 (20) | 29 (36) | 16 (20) |
| Completed slower self-paced (85 ± 1.1 steps/min (mean ± SEM, range 70–90), 9 in.) number (%) | ||||||
| Total number in group n = 24 | 0 (0) | 1 (4) | 1 (4) | 7 (29) | 9 (38) | 6 (25) |
| Active chemotherapy | ||||||
| Yes | 0 (0) | 0 (0) | 1 (20) | 1 (20) | 3 (60) | 0 (0) |
| No | 0 (0) | 1 (5) | 0 (0) | 5 (26) | 7 (37) | 6 (32) |
| Active anti-hormonal therapyd | ||||||
| Yes | 0 (0) | 1 (10) | 0 (0) | 5 (45) | 5 (45) | 0 (0) |
| No | 0 (0) | 0 (0) | 1 (8) | 2 (15) | 4 (31) | 6 (46) |
| Radiation therapy | ||||||
| Completed | 0 (0) | 1 (7) | 0 (0) | 5 (36) | 4 (29) | 4 (29) |
| None | 0 (0) | 0 (0) | 1 (10) | 2 (20) | 5 (50) | 2 (20) |
| Active | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Presence of distant metastases | ||||||
| Yes | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) |
| No | 0 (0) | 1 (4) | 1 (4) | 7 (30) | 8 (35) | 6 (16) |
| Completed shorter self-paced (91 ± 1.5 steps/min (mean ± SEM, range 80–96), 9 in.) number (%) | ||||||
| Total number in group n = 20e | 0 | 3 (15) | 2 (10) | 5 (25) | 6 (30) | 4 (20) |
| Active chemotherapyf | ||||||
| Yes | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 5 (71) | 2 (29) |
| No | 0 (0) | 3 (23) | 2 (15) | 5 (38) | 1 (8) | 2 (15) |
| Active anti-hormonal therapy | ||||||
| Yes | 0 (0) | 1 (13) | 2 (25) | 2 (25) | 2 (25) | 1 (13) |
| No | 0 (0) | 2 (17) | 0 (0) | 3 (25) | 4 (33) | 3 (25) |
| Radiation therapy | ||||||
| Completed | 0 (0) | 2 (18) | 2 (18) | 2 (18) | 3 (27) | 2 (18) |
| None | 0 (0) | 1 (11) | 0 (0) | 3 (33) | 3 (33) | 2 (22) |
| Active | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Presence of distant metastases | ||||||
| Yes | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 0 (0) |
| No | 0 (0) | 3 (17) | 1 (6) | 5 (28) | 5 (28) | 4 (22) |
aN = 1 excluded from analyses for exercise-induced arrhythmia.
bp = 0.0018, Fisher's exact, two-tailed.
cp = 0.0347, Fisher's exact, two-tailed.
dp = 0.0238, Fisher's exact, two-tailed.
eN = 1 excluded from analyses as pulse recovery not determined.
fp = 0.0103, Fisher's exact, two-tailed.